2020-2027 Analysis and Review Ketotifen Fumarate Market

Ketotifen Fumarate Market

Ketotifen Fumarate Market By Indication (Atopic Asthma, Allergic Seasonal Conjunctivitis, Chronic Urticaria and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

24-02-2020 REP-HC-5039 40 Tables 117 pages Format

The ketotifen fumarate market was valued at USD2,301.9 Mn by 2019. Rising prevalence of allergic reactions worldwide and constant rise in the air pollutant, allergens, pollen, and animal dander together drive the ketotifen fumarate market growth. Furthermore, the availability of generic versions of different formulation types and OTC products further consolidate ketotifen fumarate market growth.

 Ketotifen Fumarate Market

Ketotifen fumarate is classified as a cyclohepta thiophene blocker of the H1 receptor and finds huge clinical applications in the treatment of allergic reactions associated with asthma, conjunctivitis, atopic dermatitis, and chronic urticaria, etc. It specifically inhibits the release of inflammatory mediators from the mast cells which are engaged in the hypersensitivity reactions. It also potentially decreases the chemotaxis and inhibits the cAMP phosphodiesterase and exerts its antiallergic activity.

The major segments related to the ketotifen fumarate market are:

By Indication (2017–2027; US$ Mn)

Atopic Asthma

Allergic Seasonal Conjunctivitis

Chronic Urticaria


By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy


Geography Segment(2017–2027; US$ Mn)

North America

United States


United Kingdom
Rest of Europe

Asia Pacific

Rest of Asia Pacific

Latin America (LATAM)

Rest of Latin America

Middle East and Africa (MEA)

Rest of MEA

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global ketotifen fumarate market
  • The overall segmentation of the ketotifen fumarate market, by indication, distribution channel, and geography is minutely studied. Atopic Asthma and hospital pharmacy are dominating the indication and distribution channel segments respectively
  • Rising prevalence of allergic reactions due to the significant rise in pollutants, dust, pollen, and animal dander primarily increase the demand for ketotifen fumarate drugs for the treatment
  • Availability of ketotifen fumarate drug formulation as over the counter products further accentuates its market growth

Report gist?

  • The study of the global ketotifen fumarate market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of indication and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027
  • The study includes the profiles of major market players with a significant global and regional presence along with top company positioning

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical companies engaged in manufacturing and marketing of ketotifen fumarate which is gaining huge demand owing to the rising prevalence of allergic reactions in human beings throughout the globe
  • The report will benefit physicians engaged in prescribing ketotifen fumarate formulations for allergic reaction treatment
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to ketotifen fumarate market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Atopic asthma is spearheading the indication segment for ketotifen fumarate market growth. As per the latest information catered by the Global Asthma Report 2018, asthma is responsible for the death of 1000 people daily and approximately affects 339 million people across the globe. It is used as a prophylactic agent in pediatrics for the treatment of atopic asthma as it is a basophil and mast cell stabilizer and a potent H1 receptor antagonist. Allergic seasonal conjunctivitis is set to witness lucrative market opportunity on account of the rising prevalence of air and water pollutions and allergens which are the primary causative agent for the disease progression of allergic seasonal conjunctivitis. The availability of different ophthalmic solutions as generic and OTC products further buttress its market growth.

Hospital pharmacy is ruling the distribution channel segment for the ketotifen fumarate market. The chief attributing factor which propels its market growth is the immaculate compounding of ketotifen fumarate drug formulation across all age groups to prevent any adverse effects associated with overdose drug toxicity. Retail pharmacy is gaining huge prominence in the developing regions owing to the availability if ketotifen fumarate drug formulations as over the counter products.

North America is currently leading the geography segment for the ketotifen fumarate market. As per the research citings brought forward by the American Academy of Allergy Asthma & Immunology (AAAAI) approximately 50 million Americans suffer from some form of allergic disease and the number is anticipated to increase during the forecast period. Favorable reimbursement scenario associated with ketotifen fumarate drug formulations and domicile of major players such as Bausch & Lomb, Allergan, Plc., Apotex Corp., Novartis Pharma AG. etc., further fortifies the ketotifen fumarate market growth in the region. Europe stands in the 2nd position in the regional market on account of the rising prevalence of asthma in the region. As per the statistics presented by the European Respiratory Society (ERS), approximately 30 million children and adults suffer from allergic asthma. Supportive regulatory environment provided by the European Medical Agency (EMA), buttress the ketotifen fumarate market growth in the region. Asia Pacific is set to register magnificent market growth owing to the presence of huge generic market and growing incidence of allergic seasonal conjunctivitis owing to dust, pollution, pollen, and animal dander.

Select License Type


Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.